1. Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia. Issue 164 (April 2018) Authors: Alberelli, M.A.; Innocenti, I.; Autore, F.; Sica, S.; Laurenti, L.; De Candia, E. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE. (23rd June 2022) Authors: Stirparo, L.; Autore, F.; Innocenti, I.; Papa, E.; Marchesi, F.; Togni, C.; Mariani, S.; Torrieri, L.; Salvatori, M.; Fazio, F.; Metafuni, E.; Giammarco, S.; Sorà, F.; Falcucci, P.; Ferrari, A.; Trisolini, S. M.; Tafuri, A.; Chiusolo, P.; Sica, S.; Laurenti, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB1872: ANTIBODY RESPONSES AFTER COVID-19 VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA, EITHER TREATED OR NAÏVE. A MONOCENTRIC EXPERIENCE. (23rd June 2022) Authors: Innocenti, I.; Benintende, G.; Stirparo, L.; Tomasso, A.; Mosca, A.; Fresa, A.; Galli, E.; Autore, F.; Laurenti, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗